Fox Run Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-31,275
| Closed | -$717K | – | 1004 |
|
|
2023
Q4 | $717K | Buy |
+31,275
| New | +$717K | 0.18% | 177 |
|
|
2023
Q3 | – | Sell |
-27,931
| Closed | -$771K | – | 936 |
|
|
2023
Q2 | $771K | Buy |
+27,931
| New | +$771K | 0.22% | 149 |
|
|
2023
Q1 | – | Sell |
-28,970
| Closed | -$316K | – | 881 |
|
|
2022
Q4 | $316K | Sell |
28,970
-11,713
| -29% | -$128K | 0.13% | 324 |
|
|
2022
Q3 | $343K | Buy |
+40,683
| New | +$343K | 0.13% | 306 |
|